NMRA-215

Neumora Therapeutics Announces Positive NMRA-215 Toxicology Findings

WATERTOWN, Mass., July 27, 2026 Neumora Therapeutics announced positive preclinical toxicology results for NMRA-215, its investigational brain-penetrant oral NLRP3...

By cGxPwire Editor
July 28, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

NMRA-215

Neumora Therapeutics Announces Positive NMRA-215 Toxicology Findings